Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Digestive SystemDRG 395-other-digestive-system-diagnoses-without-cc-mcc
    Ask Trek AI about this page

    Other Digestive System Diagnoses without CC/MCC: Inpatient Reimbursement Overview

    DRG 395 groups inpatient stays for other digestive system diagnoses without Complication or Comorbidity or Major Complication or Comorbidity and reflects lower clinical severity. It matters for inpatient reimbursement because payment is calibrated to the absence of higher-severity diagnoses, influencing hospital revenue for routine digestive admissions.

    Customize your policy alerts

    Sign up for drg 395 policy alerts

    Get alerted when payer policies referencing 395 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 395 Overview

    DRG 395 covers inpatient admissions for other digestive system diagnoses without Complication or Comorbidity or Major Complication or Comorbidity. Typical cases include non-complicated gastrointestinal conditions, minor biliary disorders, and diagnostic evaluations that do not meet higher severity criteria. This grouping matters for Medicare payment because it assigns a lower relative weight and payment level compared with cases that include Complication or Comorbidity or Major Complication or Comorbidity, affecting hospital reimbursement for routine digestive admissions.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute procedural and perioperative management studies: trials evaluating optimal approaches to endoscopic, surgical, or interventional procedures for non-complex digestive diagnoses (for example, endoscopic hemostasis strategies for bleeding peptic ulcers, procedural timing for obstructive biliary conditions without major comorbidity, or minimally invasive versus conventional techniques for benign small-bowel resections). These studies enroll hospitalized adults presenting with acute but non-MCC-bearing digestive conditions, focusing on procedural success, short-term complications, and length of stay. Findings directly inform inpatient resource utilization, complication rates, and procedural choice decisions that affect reimbursement and case-mix assignment for DRG 395 patients.
    • Comparative effectiveness and care pathway trials for medical management: randomized or pragmatic studies comparing non-surgical medical strategies such as antibiotic stewardship approaches, acid-suppression regimens, or standardized protocols for opioid-sparing pain control and bowel rest in patients with acute, non-complicated digestive conditions (for example, mild pancreatitis or uncomplicated diverticulitis managed without major complications). These trials target adult inpatients and observation stays to determine which medical pathways reduce readmissions, complications, and length of stay. Results are relevant to clinicians and payers because they can identify cost-effective care bundles and protocols that reduce utilization while maintaining clinical quality for cases categorized in DRG 395.
    • Post-discharge outcomes, transitions of care, and quality-of-life studies: cohort and interventional studies assessing discharge planning, outpatient follow-up timing, nutrition support, and patient-reported outcomes for patients hospitalized with non-complex digestive disorders (for example, monitoring recurrence, functional recovery, and outpatient resource use after hospitalization for non-complicated GI bleeding or inflammatory colitis). These studies include efforts to reduce preventable readmissions and emergency visits through enhanced discharge interventions and care coordination. The evidence guides hospitals and payers on effective transitional care strategies that can lower downstream costs and improve value for the DRG 395 population.

    Related Codes

    326-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-MCC

    Stomach, Esophageal and Duodenal Procedures with MCC: Inpatient Reimbursement Overview

    327-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-CC

    Stomach, Esophageal and Duodenal Procedures with CC: Inpatient Reimbursement Overview

    328-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITHOUT-CC-MCC

    Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

    329-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-MCC

    Major Small and Large Bowel Procedures with MCC: Inpatient Reimbursement Overview

    330-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-CC

    Major Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview

    331-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITHOUT-CC-MCC

    Major Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

    332-RECTAL-RESECTION-WITH-MCC

    Rectal Resection with MCC: Inpatient Reimbursement Overview

    333-RECTAL-RESECTION-WITH-CC

    Rectal Resection with CC: Inpatient Reimbursement Overview

    334-RECTAL-RESECTION-WITHOUT-CC-MCC

    Rectal Resection without CC/MCC: Inpatient Reimbursement Overview

    335-PERITONEAL-ADHESIOLYSIS-WITH-MCC

    Peritoneal Adhesiolysis with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 57

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.